[ Contents | Search | Next | Previous | Up ]
From: Ora McCreary
Date: 12 Oct 2010
Time: 09:00:58 -0500
Remote Name: 98.14.249.93
I hope one of the experts on this panel will be able to provide more information on pagaclone or what we might expect from it. The success/failure of pagolone is a significant issue for me, personally, as a lifelong stutterer. And from what I've read and heard, many other stutterers have been also paying close attention to this issue. Jerry Maguire's talk was one of the best attended at the 2009 NSA convention, so clearly there's some interest in the stuttering community. I would imagine that the SLP community would be also be following the pagoclone developments with great interest, since it seems that a successful drug could be a significant aid as a component of speech therapy. Do any of the experts here have any further information regarding pagoclone, or any informed speculation as to its potential success or failure? If not, perhaps you could comment on whether it's likely that a drug to limit stuttering will ever be available, and if so, what would be the role of such a drug in speech therapy. Do you think it could it become a useful component of an SLP's treatment?